Market

Is Leadership Reshaping the Future of Biopharma CDMOs?
Biotech & Bioprocessing Is Leadership Reshaping the Future of Biopharma CDMOs?

The biopharmaceutical sector has witnessed significant changes in leadership roles within major Contract Development and Manufacturing Organizations (CDMOs), driving strategic growth and development. The appointment of seasoned leaders plays a crucial role in strengthening the research,

Will Bioinformatics Transform Drug Discovery and Genomic Research?
Tech & Innovation Will Bioinformatics Transform Drug Discovery and Genomic Research?

The global bioinformatics market is witnessing unprecedented growth, driven by significant advances in sequencing technologies and heightened interest in personalized medicine. As bioinformatics continues to evolve, its impact on drug discovery and genomic research becomes increasingly profound.

Immunovant Shifts Focus to Next-Gen Drug IMVT-1402 Amid Trial Success
Research & Development Immunovant Shifts Focus to Next-Gen Drug IMVT-1402 Amid Trial Success

Immunovant, a biotechnology company known for its innovative treatments for autoimmune diseases, has recently announced a significant shift in its development strategy. Despite late-stage successes with its experimental drug batoclimab, the company has decided to momentarily hold back on seeking

How Will Medical Holography Transform Healthcare by 2029?
Management & Regulatory How Will Medical Holography Transform Healthcare by 2029?

The dawn of holography technology marks a revolutionary period in healthcare, enhancing diagnostic capabilities, surgical planning, and medical education. With predictions of the global medical holography market reaching $7.11 billion by 2029, the healthcare sector stands on the brink of profound

Can Europe's Medical Gloves Market Overcome Environmental Challenges?
Management & Regulatory Can Europe's Medical Gloves Market Overcome Environmental Challenges?

The Europe medical gloves market, valued at USD 4.35 billion in 2024, is set to grow steadily, reaching USD 7.89 billion by 2033. As healthcare demands rise, so does the reliance on medical gloves—a critical component in infection control. However, environmental concerns loom large over this b

How Will Repligen's Acquisition of 908 Devices Enhance Bioprocessing?
Biotech & Bioprocessing How Will Repligen's Acquisition of 908 Devices Enhance Bioprocessing?

Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later